Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL

NCT00577161 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped closed to enrollment

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: fludarabine and rituximab
DRUG: fludarabine, rituximab, pixantrone

Sponsor

CTI BioPharma